• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Sonire Therapeutics Raises $18M to Transform Pancreatic Cancer Treatment

by Fred Pennic 04/15/2026 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Sonire Therapeutics Raises $18M to Transform Pancreatic Cancer Treatment

What You Should Know

  • The Raise: Clinical-stage medical device company Sonire Therapeutics has announced an $18M Series A financing round. The round was led by Santé Ventures, with participation from Fast Track Initiative (FTI), Nomura SPARX Investment, and SBI Investment.
  • The Technology: Sonire has developed a proprietary High-Intensity Focused Ultrasound (HIFU) therapy system for the non-invasive thermal ablation of solid tumors.
  • The Clinical Target: The company is initially focusing on pancreatic cancer, a notoriously lethal disease with a 5-year survival rate of only 12% and very limited local therapy options. The device received an FDA Breakthrough Device Designation in 2024.
  • The Workflow Disruption: Unlike conventional ultrasound-guided HIFU systems, Sonire’s solution provides clear real-time visualization, requires no anesthesia, and can be performed on an outpatient basis in roughly 20 minutes. It also only requires one physician to administer, drastically lowering the staffing burden.

A New Approach to Lethal Solid Tumors

Pancreatic cancer remains a devastating diagnosis with a 5-year survival rate of just 12%. Current local therapy options are limited, leaving a high unmet medical need for patients. Sonire’s proprietary HIFU system is designed to prolong survival when combined with chemotherapy, offering a safer alternative to traditional surgery or radiation.

Unlike conventional ultrasound-guided systems, Sonire’s technology provides several key clinical advantages:

  • Enhanced Visualization: Patented noise-cancellation and cavitation bubble visualization allow for clear, real-time imaging of the treatment site.
  • Outpatient Convenience: The procedure typically takes only 20 minutes, requires no anesthesia, and is performed on an outpatient basis.
  • Operational Efficiency: The system is robot-assisted and requires only one physician to administer, reducing the staffing burden and cost for hospitals.
  • Precision Engineering: Advanced multi-focus scanning enables precise thermal ablation of tumors.

Landmark Clinical Progress

The funding will support the completion of the SUNRISE-I randomized controlled trial in Japan. This study is the world’s first of its kind to evaluate HIFU combined with chemotherapy specifically for pancreatic cancer. Early foundational work using a prototype system demonstrated a 66% disease control rate in patients with advanced pancreatic and biliary tract cancers.

With 25 issued patents and its 2024 FDA Breakthrough Device Designation, Sonire is now expanding its corporate footprint from Tokyo to its new headquarters in Palo Alto, California.

Scaling for Global Impact

“Our goal is to deliver a new standard of care that gives patients more time and better quality of life,” said Tohru Satoh, President and CEO of Sonire Therapeutics. As the company prepares for U.S. clinical and regulatory milestones, it aims to prove that next-generation acoustic engineering can solve the core challenges of precision and workflow that have historically limited the field of oncology.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Cancer Diagnostics, Oncology Digital Health Startups, Oncology Platform

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

CB Insights’ 2026 Digital Health 50 Reveals How Agentic AI Is Becoming the Clinical Provider and Medication Access Engine

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |